메뉴 건너뛰기




Volumn 80, Issue 12, 2006, Pages 6136-6145

Functional correlation between a novel amino acid insertion at codon 19 in the protease of human immunodeficiency virus type 1 and polymorphism in the p1/p6 Gag cleavage site in drug resistance and replication fitness

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; AMPRENAVIR; ATAZANAVIR; GAG PROTEIN; INDINAVIR; LEUCINE; LOPINAVIR; NELFINAVIR; PROLINE; PROTEINASE; PROTEINASE INHIBITOR; RITONAVIR; SAQUINAVIR; ZIDOVUDINE;

EID: 33744912483     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.02212-05     Document Type: Article
Times cited : (20)

References (45)
  • 1
    • 0022495870 scopus 로고
    • Production of acquired immunodeficiency syndrome-associated retroviras in human and nonhuman cells transfected with an infectious molecular clone
    • Adachi, A., H. E. Gendelman, S. Koenig, T. Folks, R. Willey, A. Rabson, and M. A. Martin. 1986. Production of acquired immunodeficiency syndrome-associated retroviras in human and nonhuman cells transfected with an infectious molecular clone. J. Virol. 59:284-291.
    • (1986) J. Virol. , vol.59 , pp. 284-291
    • Adachi, A.1    Gendelman, H.E.2    Koenig, S.3    Folks, T.4    Willey, R.5    Rabson, A.6    Martin, M.A.7
  • 2
    • 0034284897 scopus 로고    scopus 로고
    • Polymorphism of HIV type 1 gag p7/p1 and p1/p6 cleavage sites: Clinical significance and implications for resistance to protease inhibitors
    • Bally, F., R. Martinez, S. Peters, P. Sudre, and A. Telenti. 2000. Polymorphism of HIV type 1 gag p7/p1 and p1/p6 cleavage sites: clinical significance and implications for resistance to protease inhibitors. AIDS Res. Hum. Retrovir. 16:1209-1213.
    • (2000) AIDS Res. Hum. Retrovir. , vol.16 , pp. 1209-1213
    • Bally, F.1    Martinez, R.2    Peters, S.3    Sudre, P.4    Telenti, A.5
  • 3
    • 0031849665 scopus 로고    scopus 로고
    • In vitro selection and characterization of human immunodeficiency virus type 1 variants with increased resistance to ABT-378, a novel protease inhibitor
    • Carrillo, A., K. D. Stewart, H. L. Sham, D. W. Norbeck, W. E. Kohlbrenner, J. M. Leonard, D. J. Kempf, and A. Molla. 1998. In vitro selection and characterization of human immunodeficiency virus type 1 variants with increased resistance to ABT-378, a novel protease inhibitor. J. Virol. 72:7532-7541.
    • (1998) J. Virol. , vol.72 , pp. 7532-7541
    • Carrillo, A.1    Stewart, K.D.2    Sham, H.L.3    Norbeck, D.W.4    Kohlbrenner, W.E.5    Leonard, J.M.6    Kempf, D.J.7    Molla, A.8
  • 4
    • 0034565934 scopus 로고    scopus 로고
    • HIV drug resistance and viral fitness
    • Clavel, F., E. Race, and F. Mammano. 2000. HIV drug resistance and viral fitness. Adv. Pharmacol. 49:41-66.
    • (2000) Adv. Pharmacol. , vol.49 , pp. 41-66
    • Clavel, F.1    Race, E.2    Mammano, F.3
  • 5
    • 0035163687 scopus 로고    scopus 로고
    • Human immunodeficiency virus type 1 protease cleavage site mutations associated with protease inhibitor cross-resistance selected by indinavir, ritonavir, and/or saquinavir
    • Cote, H. C., Z. L. Brumme, and P. R. Harrigan. 2001. Human immunodeficiency virus type 1 protease cleavage site mutations associated with protease inhibitor cross-resistance selected by indinavir, ritonavir, and/or saquinavir. J. Virol. 75: 589-594.
    • (2001) J. Virol. , vol.75 , pp. 589-594
    • Cote, H.C.1    Brumme, Z.L.2    Harrigan, P.R.3
  • 6
    • 0031015475 scopus 로고    scopus 로고
    • Impaired fitness of human immunodeficiency virus type 1 variants with high-level resistance to protease inhibitors
    • Croteau, G., L. Doyon, D. Thibeault, G. McKercher, L. Pilote, and D. Lamarre. 1997. Impaired fitness of human immunodeficiency virus type 1 variants with high-level resistance to protease inhibitors. J. Virol. 71:1089-1096.
    • (1997) J. Virol. , vol.71 , pp. 1089-1096
    • Croteau, G.1    Doyon, L.2    Thibeault, D.3    McKercher, G.4    Pilote, L.5    Lamarre, D.6
  • 7
    • 0033552832 scopus 로고    scopus 로고
    • Insertion of two amino acids combined with changes in reverse transcriptase containing tyrosine-215 of HIV-1 resistant to multiple nucleoside analogs
    • de Jong, J. J., J. Goudsmit, V. V. Lukashov, M. E. Hillebrand, E. Baan, R. Huismans, S. A. Danner, J. H. ten Veen, F. de Wolf, and S. Jurriaans. 1999. Insertion of two amino acids combined with changes in reverse transcriptase containing tyrosine-215 of HIV-1 resistant to multiple nucleoside analogs. AIDS 13:75-80.
    • (1999) AIDS , vol.13 , pp. 75-80
    • Jong, J.J.1    Goudsmit, J.2    Lukashov, V.V.3    Hillebrand, M.E.4    Baan, E.5    Huismans, R.6    Danner, S.A.7    Ten Veen, J.H.8    De Wolf, F.9    Jurriaans, S.10
  • 10
    • 0029899093 scopus 로고    scopus 로고
    • Second locus involved in human immunodeficiency virus type 1 resistance to protease inhibitors
    • Doyen, L., G. Croteau, D. Thibeault, F. Poulin, L. Pilote, and D. Lamarre. 1996. Second locus involved in human immunodeficiency virus type 1 resistance to protease inhibitors. J. Virol. 70:3763-3769.
    • (1996) J. Virol. , vol.70 , pp. 3763-3769
    • Doyen, L.1    Croteau, G.2    Thibeault, D.3    Poulin, F.4    Pilote, L.5    Lamarre, D.6
  • 11
    • 0017289168 scopus 로고
    • Ultrastructural studies of surface features of human normal and tumor cells in tissue culture by scanning and transmission electron microscopy
    • Gonda, M. A., S. A. Aaronson, N. Ellmore. V. H. Zeve, and K. Nagashima. 1976. Ultrastructural studies of surface features of human normal and tumor cells in tissue culture by scanning and transmission electron microscopy. J. Natl. Cancer Inst. 56:245-263.
    • (1976) J. Natl. Cancer Inst. , vol.56 , pp. 245-263
    • Gonda, M.A.1    Aaronson, S.A.2    Ellmore, N.3    Zeve, V.H.4    Nagashima, K.5
  • 12
    • 0023926115 scopus 로고
    • Metabolism and anti-human immunodeficiency virus-1 activity of 2-halo-2′,3′-dideoxyadenosine derivatives
    • Haertle, T., C. J. Carrera, D. B. Wasson, L. C. Sowers, D. D. Richman, and D. A. Carson. 1988. Metabolism and anti-human immunodeficiency virus-1 activity of 2-halo-2′,3′-dideoxyadenosine derivatives. J. Biol. Chem. 263: 5870-5875.
    • (1988) J. Biol. Chem. , vol.263 , pp. 5870-5875
    • Haertle, T.1    Carrera, C.J.2    Wasson, D.B.3    Sowers, L.C.4    Richman, D.D.5    Carson, D.A.6
  • 13
    • 0022404296 scopus 로고
    • Infection of HTLV-III/LAV in HTLV-carrying cells MT-2 and MT-4 and application in a plaque assay
    • Harada, S., Y. Koyanagi, and N. Yamamoto. 1985. Infection of HTLV-III/LAV in HTLV-carrying cells MT-2 and MT-4 and application in a plaque assay. Science 229:563-566.
    • (1985) Science , vol.229 , pp. 563-566
    • Harada, S.1    Koyanagi, Y.2    Yamamoto, N.3
  • 14
    • 0031958266 scopus 로고    scopus 로고
    • Relative replicative fitness of zidovudine-resistant human immunodeficiency virus type 1 isolates in vitro
    • Harrigan, P. R., B. Stuart, and B. A. Larder. 1998. Relative replicative fitness of zidovudine-resistant human immunodeficiency virus type 1 isolates in vitro. J. Virol. 72:3773-3778.
    • (1998) J. Virol. , vol.72 , pp. 3773-3778
    • Harrigan, P.R.1    Stuart, B.2    Larder, B.A.3
  • 15
    • 0034469498 scopus 로고    scopus 로고
    • Relative replication fitness of a high-level 3′Azido-3′- deoxythimidien resistant variant of human Immunodeficiency virus type-1 possessing an amino acid deletion at codon 67 and a novel substitution (Thr to Gly) at codon 69
    • Imamichi, T., S. C. Berg, H. Imamichi, J. C. Lopez, J. A. Metcalf, J. Falloon, and H. C. Lane. 2000. Relative replication fitness of a high-level 3′Azido-3′-deoxythimidien resistant variant of human Immunodeficiency virus type-1 possessing an amino acid deletion at codon 67 and a novel substitution (Thr to Gly) at codon 69. J. Virol. 74:10958-10964.
    • (2000) J. Virol. , vol.74 , pp. 10958-10964
    • Imamichi, T.1    Berg, S.C.2    Imamichi, H.3    Lopez, J.C.4    Metcalf, J.A.5    Falloon, J.6    Lane, H.C.7
  • 16
    • 0742290185 scopus 로고    scopus 로고
    • HIV type 1 genotypic resistance in a clinical database correlates with antiretroviral utilization
    • Kagan, R., M. Winters, T. Merigan, and P. Heseltine. 2004. HIV type 1 genotypic resistance in a clinical database correlates with antiretroviral utilization. AIDS Res. Hum. Retrovir. 20:1-9.
    • (2004) AIDS Res. Hum. Retrovir. , vol.20 , pp. 1-9
    • Kagan, R.1    Winters, M.2    Merigan, T.3    Heseltine, P.4
  • 18
    • 0034764066 scopus 로고    scopus 로고
    • Functional correlates of insertion mutations in the protease gene of human immunodeficiency virus type 1 isolates from patients
    • Kim, E. Y., M. A. Winters, R. M. Kagan, and T. C. Merigan. 2001. Functional correlates of insertion mutations in the protease gene of human immunodeficiency virus type 1 isolates from patients. J. Virol. 75:11227-11233.
    • (2001) J. Virol. , vol.75 , pp. 11227-11233
    • Kim, E.Y.1    Winters, M.A.2    Kagan, R.M.3    Merigan, T.C.4
  • 22
    • 0036063882 scopus 로고    scopus 로고
    • Genotypic and phenotypic analysis of a novel 15-base insertion occurring between codons 69 and 70 of HIV type 1 reverse transcriptase
    • Lobato, R. L., E. Y. Kim, R. M. Kagan, and T. C. Merigan. 2002. Genotypic and phenotypic analysis of a novel 15-base insertion occurring between codons 69 and 70 of HIV type 1 reverse transcriptase. AIDS Res. Hum. Retrovir. 18:733-736.
    • (2002) AIDS Res. Hum. Retrovir. , vol.18 , pp. 733-736
    • Lobato, R.L.1    Kim, E.Y.2    Kagan, R.M.3    Merigan, T.C.4
  • 24
    • 0031846317 scopus 로고    scopus 로고
    • Resistance-associated loss of viral fitness in human immunodeficiency virus type 1: Phenotypic analysis of protease and gag coevolution in protease inhibitor-treated patients
    • Mammano, F., C. Petit, and F. Clavel. 1998. Resistance-associated loss of viral fitness in human immunodeficiency virus type 1: phenotypic analysis of protease and gag coevolution in protease inhibitor-treated patients. J. Virol. 72:7632-7637.
    • (1998) J. Virol. , vol.72 , pp. 7632-7637
    • Mammano, F.1    Petit, C.2    Clavel, F.3
  • 26
    • 0032928065 scopus 로고    scopus 로고
    • Replicative fitness of protease inhibitor-resistant mutants of human immunodeficiency virus type 1
    • Martinez-Picado, J., A. V. Savara, L. Sutton, and R. T. D'Aquila. 1999. Replicative fitness of protease inhibitor-resistant mutants of human immunodeficiency virus type 1. J. Virol. 73:3744-3752.
    • (1999) J. Virol. , vol.73 , pp. 3744-3752
    • Martinez-Picado, J.1    Savara, A.V.2    Sutton, L.3    D'Aquila, R.T.4
  • 28
    • 0032804864 scopus 로고    scopus 로고
    • Increased fitness of drug resistant HIV-1 protease as a result of acquisition of compensatory mutations during suboptimal therapy
    • Nijhuis, M., R. Schuurman, D. de Jong, J. Erickson, E. Gustchina, J. Albert, P. Schipper, S. Gulnik, and C. A. Boucher. 1999. Increased fitness of drug resistant HIV-1 protease as a result of acquisition of compensatory mutations during suboptimal therapy. AIDS 13:2349-2359.
    • (1999) AIDS , vol.13 , pp. 2349-2359
    • Nijhuis, M.1    Schuurman, R.2    De Jong, D.3    Erickson, J.4    Gustchina, E.5    Albert, J.6    Schipper, P.7    Gulnik, S.8    Boucher, C.A.9
  • 33
    • 0034632745 scopus 로고    scopus 로고
    • HIV type 1 protease cleavage site mutations and viral fitness: Implications for drug susceptibility phenotyping assays
    • Robinson, L. H., R. E. Myers, B. W. Snowden, M. Tisdale, and E. D. Blair. 2000. HIV type 1 protease cleavage site mutations and viral fitness: implications for drug susceptibility phenotyping assays. AIDS Res. Hum. Retrovir. 16:1149-1156.
    • (2000) AIDS Res. Hum. Retrovir. , vol.16 , pp. 1149-1156
    • Robinson, L.H.1    Myers, R.E.2    Snowden, B.W.3    Tisdale, M.4    Blair, E.D.5
  • 34
    • 0001113422 scopus 로고    scopus 로고
    • Mutations in retroviral genes associated with drug resistance: 1999-2000 update
    • Schinazi, R. F., B. A. Larder, and J. W. Mellors. 2000. Mutations in retroviral genes associated with drug resistance: 1999-2000 update. Int. Antivir. News 7:46-69.
    • (2000) Int. Antivir. News , vol.7 , pp. 46-69
    • Schinazi, R.F.1    Larder, B.A.2    Mellors, J.W.3
  • 35
    • 18544407086 scopus 로고    scopus 로고
    • A 6-base pair insertion in the protease gene of HIV type 1 detected in a protease inhibitor-naive patient is not associated with indinavir treatment failure
    • Sturmer, M., S. Staszewski, H. W. Doerr, and K. Hertogs. 2003. A 6-base pair insertion in the protease gene of HIV type 1 detected in a protease inhibitor-naive patient is not associated with indinavir treatment failure. AIDS Res. Hum. Retrovir. 19:967-968.
    • (2003) AIDS Res. Hum. Retrovir. , vol.19 , pp. 967-968
    • Sturmer, M.1    Staszewski, S.2    Doerr, H.W.3    Hertogs, K.4
  • 36
    • 20444387210 scopus 로고    scopus 로고
    • Detection of a new 3-base pair insertion mutation in the protease gene of human immunodeficiency virus type 1 during highly active antiretroviral therapy (HAART)
    • Tramuto, F., F. Bonura, S. Mancuso, N. Romano, and F. Vitale. 2005. Detection of a new 3-base pair insertion mutation in the protease gene of human immunodeficiency virus type 1 during highly active antiretroviral therapy (HAART). AIDS Res. Hum. Retrovir. 21:420-423.
    • (2005) AIDS Res. Hum. Retrovir. , vol.21 , pp. 420-423
    • Tramuto, F.1    Bonura, F.2    Mancuso, S.3    Romano, N.4    Vitale, F.5
  • 37
    • 14744272822 scopus 로고    scopus 로고
    • Increased multinucleoside drug resistance and decreased replicative capacity of a human immunodeficiency virus type 1 variant with an 8-amino-acid insert in the reverse transcriptase
    • van der Hoek, L., N. Back, M. F. Jebbink, A. de Ronde, M. Bakker, S. Jurriaans, P. Reiss, N. Parkin, and B. Berkhout. 2005. Increased multinucleoside drug resistance and decreased replicative capacity of a human immunodeficiency virus type 1 variant with an 8-amino-acid insert in the reverse transcriptase. J. Virol. 79:3536-3543.
    • (2005) J. Virol. , vol.79 , pp. 3536-3543
    • Van Der Hoek, L.1    Back, N.2    Jebbink, M.F.3    De Ronde, A.4    Bakker, M.5    Jurriaans, S.6    Reiss, P.7    Parkin, N.8    Berkhout, B.9
  • 39
    • 0032533207 scopus 로고    scopus 로고
    • A 6-basepair insert in the reverse transcriptase gene of human immunodeficiency virus type 1 confers resistance to multiple nucleoside inhibitors
    • Winters, M. A., K. L. Coolley, Y. A. Girard, D. J. Levee, H. Hamdan, R. W. Shafer, D. A. Katzenstein, and T. C. Merigan. 1998. A 6-basepair insert in the reverse transcriptase gene of human immunodeficiency virus type 1 confers resistance to multiple nucleoside inhibitors. J. Clin. Investig. 102: 1769-1775.
    • (1998) J. Clin. Investig. , vol.102 , pp. 1769-1775
    • Winters, M.A.1    Coolley, K.L.2    Girard, Y.A.3    Levee, D.J.4    Hamdan, H.5    Shafer, R.W.6    Katzenstein, D.A.7    Merigan, T.C.8
  • 40
  • 41
    • 0027218692 scopus 로고
    • Structure-based inhibitors of HIV-1 protease
    • Wlodawer, A., and J. W. Erickson. 1993. Structure-based inhibitors of HIV-1 protease. Annu. Rev. Biochem. 62:543-583.
    • (1993) Annu. Rev. Biochem. , vol.62 , pp. 543-583
    • Wlodawer, A.1    Erickson, J.W.2
  • 42
    • 20244387096 scopus 로고    scopus 로고
    • Mutation patterns and structural correlates in human immunodeficiency virus type 1 protease following different protease inhibitor treatments
    • Wu, T. D., C. A. Schiffer, M. J. Gonzales, J. Taylor, R. Kantor, S. Chou, D. Israelski, A. R. Zolopa, W. J. Fessel, and R. W. Shafer. 2003. Mutation patterns and structural correlates in human immunodeficiency virus type 1 protease following different protease inhibitor treatments. J. Virol. 77:4836-4847.
    • (2003) J. Virol. , vol.77 , pp. 4836-4847
    • Wu, T.D.1    Schiffer, C.A.2    Gonzales, M.J.3    Taylor, J.4    Kantor, R.5    Chou, S.6    Israelski, D.7    Zolopa, A.R.8    Fessel, W.J.9    Shafer, R.W.10
  • 44
    • 0031946007 scopus 로고    scopus 로고
    • Loss of viral fitness associated with multiple Gag and Gag-Pol processing defects in human immunodeficiency virus type 1 variants selected for resistance to protease inhibitors in vivo
    • Zennou, V., F. Mammano, S. Paulous, D. Mathez, and F. Clavel. 1998. Loss of viral fitness associated with multiple Gag and Gag-Pol processing defects in human immunodeficiency virus type 1 variants selected for resistance to protease inhibitors in vivo. J. Virol. 72:3300-3306.
    • (1998) J. Virol. , vol.72 , pp. 3300-3306
    • Zennou, V.1    Mammano, F.2    Paulous, S.3    Mathez, D.4    Clavel, F.5
  • 45
    • 0030769354 scopus 로고    scopus 로고
    • Drug resistance during indinavir-therapy is caused by mutations in the protease gene and in its Gag substrate cleavage sites
    • Zhang, Y. M., H. Imamichi, T. Imamichi, H. C. Lane, J. Falloon, M. B. Vasudevachari, and N. P. Salzman. 1997. Drug resistance during indinavir-therapy is caused by mutations in the protease gene and in its Gag substrate cleavage sites. J. Virol. 71:6662-6670.
    • (1997) J. Virol. , vol.71 , pp. 6662-6670
    • Zhang, Y.M.1    Imamichi, H.2    Imamichi, T.3    Lane, H.C.4    Falloon, J.5    Vasudevachari, M.B.6    Salzman, N.P.7


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.